New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

Prostate cancer is among the most diagnosed cancers, accounting for 26% of new cancer diagnoses in men in 2021. 1 An important factor in understanding prostate cancer prognosis is the risk of clinical ...

In this study, researchers aimed to determine whether adding apalutamide to ADT improves outcomes in high-risk prostate cancer compared to placebo plus ADT.

Radical prostatectomy, or removal of the prostate gland and surrounding tissues, is a standard surgical procedure used to treat men with prostate cancer. Robot-assisted radical prostatectomy (RARP) is ...

(Reuters Health) - - In men with localized prostate cancer discovered because they had symptoms or noticed during a work-up for another medical problem, radical prostate surgery leads to an average of ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both before and after surgery for high-risk prostate cancer, significantly ...

Clinical Trial Eligibility Criteria: A Structural Barrier to Diversity in Clinical Trial Enrollment The article by Tilki et al entitled “Adjuvant Versus Early Salvage Radiation Therapy After Radical ...

Muhimbili National Hospital (MNH) has successfully carried out prostate cancer surgery using minimally invasive techniques, ...

With long-term follow-up, mpMRI-guided salvage radiotherapy achieved excellent durable local control. The absence of in-field ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...